1117 East Devonshire, Hemet, CA, 92543 · (951) 652-2811
Beds
230
FY 2024
Star rating
1 of 5
Patient survey: 1 of 5
Net patient revenue
$178.7M
FY 2024
Net income
$26.8M
Patient care margin 13.8%
Discharges
6,707
Occupancy 43.2%
Clinicians
118
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2024 | $178.7M | $153.9M | 13.8% | $26.8M | 6,707 | $3.1M | 19.4% | 5.0% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 8.5% | US median 8.5% |
| Death rate for heart failure patients | 9% | US median 11% |
| Hospital-wide death rate within 30 days | 5.1% | US median 3.9% |
| Death rate for pneumonia patients | 16.2% | US median 15.2% |
| Death rate for stroke patients | 10.8% | US median 11.6% |
| Readmission rate for COPD | 20.3% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2023 | $175.7M | $152.9M | 12.9% | $23.5M | 7,616 | $2.8M | 21.9% | 5.6% |
| 2022 | $182.1M | $158.3M | 13.1% | $24.6M | 9,539 | $2.5M | 19.3% | 6.3% |
| 2021 | $169.5M | $157.7M | 7.0% | $13.4M | 7,852 | $2.7M | 19.2% | 7.4% |
| 2020 | $173.9M | $154.4M | 11.2% | $39.3M | 8,962 | $4.0M | 21.9% | 7.1% |
| US median 19.8% |
| Readmission rate for heart failure | 22.1% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.9% | US median 5.8% |
| Readmission rate for pneumonia | 20% | US median 17.2% |
| Complications after hip or knee replacement | 4% | US median 4.1% |
| Serious complications (patient safety composite) | 0.87 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.32 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.23 | US median 0.48 |
| MRSA bloodstream infections (ratio to expected) | 0.44 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.00 | US median 0.40 · better |
| Doctors always communicated well | 65% | US median 79% |
| Nurses always communicated well | 67% | US median 80% |
| Patient survey summary star rating | 1 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 36% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 44% | US median 72% |
| Room and bathroom always clean | 52% | US median 73% |
| Patients who would definitely recommend the hospital | 39% | US median 71% |
| Patients who left the emergency department before being seen | 2% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 213 min | US median 148 min |
| Patients who got appropriate care for severe sepsis and septic shock | 48% | US median 65% |
| Healthcare workers given the flu vaccine | 23% | US median 79% |
| 50 |
| $60,384.94 |
| $13,820.52 |
| $9,867.73 |
| DRG 291 HEART FAILURE AND SHOCK WITH MCC | 48 | $54,843.69 | $13,502.96 | $10,022.34 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 45 | $53,524.64 | $13,080.93 | $10,642.23 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 33 | $46,108.67 | $10,455.15 | $7,681.44 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 33 | $37,865.61 | $8,171.73 | $5,985.69 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 30 | $91,145.60 | $17,084.13 | $13,076.55 |
| DRG 682 RENAL FAILURE WITH MCC | 28 | $58,194.21 | $15,969.68 | $11,457.18 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 28 | $47,539.32 | $11,113.14 | $8,838.11 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 26 | $215,414.65 | $52,966.96 | $40,556.82 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 23 | $59,328.87 | $16,717.70 | $12,667.88 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 18 | $37,750.50 | $8,277.94 | $5,662.18 |
| DRG 637 DIABETES WITH MCC | 16 | $72,249.94 | $13,691.06 | $11,464.10 |
| DRG 377 GASTROINTESTINAL HEMORRHAGE WITH MCC | 16 | $61,144.75 | $18,891.38 | $14,301.50 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 8011 Comprehensive Observation Services | 70 | 68 | $2,681.23 | $2,090.36 |
| APC 5191 Level 1 Endovascular Procedures | 22 | 22 | $2,869.49 | $2,207.96 |
| APC 5341 Level 1 Abdominal/Peritoneal/Biliary and Related Procedures | 15 | 15 | $3,226.46 | $2,635.67 |
| APC 5183 Level 3 Vascular Procedures | 15 | 15 | $3,122.31 | $2,405.01 |
| APC 5374 Level 4 Urology and Related Services | 14 | 11 | $3,366.16 | $2,629.24 |
| APC 5223 Level 3 Pacemaker and Similar Procedures | 13 | 13 | $11,475.58 | $8,569.01 |
| APC 5375 Level 5 Urology and Related Services | 12 | 12 | $5,061.13 | $3,917.51 |
| APC 5114 Level 4 Musculoskeletal Procedures | - | - | - | $5,338.75 |
| APC 5115 Level 5 Musculoskeletal Procedures | - | - | - | $10,771.69 |
| APC 5154 Level 4 Airway Endoscopy | - | - | - | $2,832.62 |
| APC 5182 Level 2 Vascular Procedures | - | - | - | $1,204.32 |
| APC 5212 Level 2 Electrophysiologic Procedures | - | - | - | $5,681.90 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| bioMerieux Inc | 1 | $19K |
| Aesculap, Inc. | 1 | $8,588 |
| Fisher Scientific Company L.L.C. | 1 | $2,471 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Hemet Global Medical Center is a for-profit short-term acute care hospital in Hemet, CA with 230 beds, part of Physicians for Healthy Hospitals and a 1-star overall rating.
Hemet Global Medical Center in Hemet, CA has 230 beds (fiscal year 2024 cost report); 433 beds are certified for Medicare. It discharged 6,707 inpatients that year, with 43.2% of its beds in use on average.
In fiscal year 2024 (ending 2024-12-31), Hemet Global Medical Center reported net patient revenue of $178.7M and operating expenses of $153.9M, a margin on patient care of 13.8%. After other income and expenses its net income was $26.8M (14.8% of revenue), so it made a profit that year.
Hemet Global Medical Center is part of Physicians for Healthy Hospitals, a health system with 2 hospitals based in Hemet, CA. It is a for-profit hospital.
Hemet Global Medical Center has an overall rating of 1 out of 5 stars in the official hospital quality ratings. Patients rate it 1 out of 5 stars in the patient survey.
Yes, Hemet Global Medical Center provides emergency services.
118 Medicare clinicians list Hemet Global Medical Center as a hospital they work at, most often in Internal Medicine, Emergency Medicine, Diagnostic Radiology.
In 2024, Hemet Global Medical Center had 803 Medicare inpatient stays in 25 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 206 stays; Medicare paid $19,951.59 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $30K in payments to Hemet Global Medical Center as a teaching hospital ($30K general and - for research) from 3 companies.